These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24460647)
41. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317 [TBL] [Abstract][Full Text] [Related]
42. Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Orandi BJ; Zachary AA; Dagher NN; Bagnasco SM; Garonzik-Wang JM; Van Arendonk KJ; Gupta N; Lonze BE; Alachkar N; Kraus ES; Desai NM; Locke JE; Racusen LC; Segev DL; Montgomery RA Transplantation; 2014 Oct; 98(8):857-63. PubMed ID: 25121475 [TBL] [Abstract][Full Text] [Related]
43. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report. Ranghino A; Tognarelli G; Basso E; Messina M; Manzione AM; Daidola G; Segoloni GP Transplant Proc; 2013 Sep; 45(7):2785-7. PubMed ID: 24034049 [TBL] [Abstract][Full Text] [Related]
44. Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Alasfar S; Alachkar N Front Med (Lausanne); 2014; 1():52. PubMed ID: 25593925 [TBL] [Abstract][Full Text] [Related]
49. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development. Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI Clin Transpl; 2006; ():241-53. PubMed ID: 18365382 [TBL] [Abstract][Full Text] [Related]
50. HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines. El-Awar N; Nguyen A; Almeshari K; Alawami M; Alzayer F; Alharbi M; Sasaki N; Terasaki PI Hum Immunol; 2013 Sep; 74(9):1141-52. PubMed ID: 23756161 [TBL] [Abstract][Full Text] [Related]
51. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report. Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299 [TBL] [Abstract][Full Text] [Related]
52. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report. Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335 [TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic features and treatment response of early acute antibody-mediated rejection in Thai kidney transplant recipients: a single-center experience. Larpparisuth N; Vongwiwatana A; Vareesangthip K; Cheunsuchon B; Parichatikanon P; Premasathian N Transplant Proc; 2014; 46(2):474-6. PubMed ID: 24655992 [TBL] [Abstract][Full Text] [Related]
54. Hidden perils in a highly sensitized kidney transplant recipient. Ford S; Summers S; Cantwell L; Mulley W Nephrology (Carlton); 2012 Apr; 17 Suppl 1():9-11. PubMed ID: 22497647 [TBL] [Abstract][Full Text] [Related]